Pharmacotherapy of childhood anxiety disorders.

Christopher J. Kratochvil, Martin J. Harrington, William J. Burke, John S. March

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Anxiety disorders are among the most common psychiatric disorders of childhood, yet limited data is available regarding the use of psychotropic medications for these conditions. Until recently, much of the data on the pharmacologic treatment of pediatric anxiety disorders has consisted of case reports and small open-label studies, with the exception of pediatric obsessive-compulsive disorder (OCD), which has had a comparatively rich literature consisting of several double blind trials. This void has been lessening, however, with four double blind, placebo-controlled studies published in the past year alone. Although the majority of pharmacologic studies of pediatric anxiety continue to focus on the treatment of OCD, additional reports on treatment of generalized anxiety disorder, panic disorder, social anxiety disorder, and separation anxiety disorder have recently been published. This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders.

Original languageEnglish (US)
Pages (from-to)264-269
Number of pages6
JournalCurrent psychiatry reports
Volume4
Issue number4
DOIs
StatePublished - Aug 2002

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Pharmacotherapy of childhood anxiety disorders.'. Together they form a unique fingerprint.

Cite this